The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension.

Additionally, in studies of droxidopa for the treatment of nOH, the rate of falls and fall-related adverse events demonstrated a favorable trend (but not statistically significant) in the groups of patients receiving droxidopa versus those receiving placebo [ 15 – 17 ].

also in 1,335 other papers